Both CDK6 and RB are required for the cell cycle progression of colorectal carcinoma cells and by inhibiting the CDK6-RB axis, PD-0332991 induces the G1 cell cycle arrest and inhibits cancer cell growth. Here, RB1 is linked to colorectal carcinoma.